The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

WST

Concerning the House

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

United States · www.westpharma.com

The Long Run

FY 2010–2025 · 15 years

LineLatestCAGRTrend
Revenue$2.89B+7.5%
Gross profit$1.13B+9.9%
Operating income$584.90M+11.7%
Net income$493.70M+33.8%
Cash from ops$776.50M+13.1%
Quotation

$346.16

-6.13 (-1.7%)

52w hi$365.50
52w lo$230.63
Vol768.80K
As ofAug 13
The Verdict

Buy

Our score +0.52

Short+0.43
Medium+0.66
Long+0.43

computed 2026-08-13

By the Numbers

West Pharmaceutical Services, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$24.36B
Enterprise value$24.67B
Trailing P/E44.27x
Forward P/E34.74x
EV / EBITDA27.05x
P / S (ttm)7.32x
Profit margin17.0%
Return on equity19.1%
Revenue growth+13.8%
Earnings growth+18.1%
Debt / equity10.59
Risk Metrics
Beta vs SPX0.62
Corr SPX0.21
Annual vol47.3%
Annual ret+20.6%
Sharpe0.43
Max DD-45.3%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.22
Sector+0.12
Technical+0.33
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$353.55$352.79$346.04$346.16768.80K
Aug 12$349.66$354.57$348.59$352.29423.20K
Aug 11$351.05$354.05$348.12$351.37389.40K
Aug 10$353.89$358.67$351.52$352.13570.50K
Aug 7$348.49$356.00$347.37$354.07500.70K